Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel.
Fiche publication
Date publication
février 2017
Journal
The British journal of dermatology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CRIBIER Bernard
Tous les auteurs :
Schaller M, Almeida LM, Bewley A, Cribier B, Dlova NC, Kautz G, Mannis M, Oon HH, Rajagopalan M, Steinhoff M, Thiboutot D, Troielli P, Webster G, Wu Y, van Zuuren E, Tan J
Lien Pubmed
Résumé
Rosacea is currently treated according to subtypes. As this does not adequately address the spectrum of clinical presentation (phenotypes), it has implications for patient management. The ROSacea COnsensus panel was established to address this issue.
Mots clés
Algorithms, Consensus, Cosmeceuticals, therapeutic use, Dermatologic Agents, therapeutic use, Drug Therapy, Combination, Eye Diseases, drug therapy, Humans, Rosacea, drug therapy, Skin Care, methods, Sunscreening Agents, therapeutic use, Treatment Outcome
Référence
Br. J. Dermatol.. 2017 Feb;176(2):465-471